RRC ID 30712
Author Wang H, Cai Z, Yang F, Luo J, Satoh M, Arai Y, Li D.
Title Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer.
Journal Urology
Abstract OBJECTIVE:To evaluate the therapeutic efficacy of AxdAdB-3 with Arg-Gly-Asp (RGD)-fiber modification (AxdAdB3-F/RGD), which enables integrin-dependent infection in bladder cancers.
METHODS:Flow cytometric analysis was applied to evaluated adenovirus-mediated gene transduction into various cells. The cytopathic effects of AxdAdB3-F/RGD were evaluated in bladder cancer cell lines and a normal bladder mucosa-derived cell line (HCV29) with AxCAZ3-F/RGD (control) or AxdAdB-3. The efficacy of bladder instillation therapy with AxdAdB3-F/RGD for orthotopic bladder cancer was investigated in nude mice.
RESULTS:Expression of coxsackievirus adenovirus receptor (CAR) and integrins (αvβ3 and αvβ5) vary in different bladder cancer cell lines. The susceptibility of various cell lines to adenovirus was associated with the expression of CAR. AxdAdB-3 was more cytopathic in CAR-positive bladder cancer cells than in CAR-negative cells, whereas AxdAdB3-F/RGD caused effective oncolysis in both CAR-positive and CAR-negative bladder cancer cells. AxdAdB3-F/RGD was not cytotoxic to HCV29 cells. Direct instillation of AxdAdB3-F/RGD into the bladder of the orthotopic model, established by CAR-deficient human bladder cancer cells, inhibited tumor growth and led to significantly elongated survival.
CONCLUSION:E1A and E1B double-restricted oncolytic adenovirus with RGD fiber modification has enhanced infectivity and oncolytic effects to CAR-deficient bladder cancers, suggesting the therapeutic potential of AxdAdB3-F/RGD for bladder cancers.
Volume 83(2)
Pages 508.e13-9
Published 2014-2
DOI 10.1016/j.urology.2013.10.025
PII S0090-4295(13)01369-1
PMID 24315309
MeSH Adenoviridae* / genetics Animals Antineoplastic Agents / therapeutic use* Cell Line, Tumor Female Genetic Therapy* Humans Integrins / genetics* Mice Mice, Inbred BALB C Oligopeptides / therapeutic use* Receptors, Virus / genetics* Urinary Bladder Neoplasms / pathology Urinary Bladder Neoplasms / therapy*
IF 2.3
Times Cited 1
WOS Category UROLOGY & NEPHROLOGY
Resource
DNA material AxdAdB3-F/RGD (RDB03012).